|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.310 USD | -3.35% |
|
-2.12% | +28.33% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 12.26x | - | -0.04x | - | - | - | - | 193M | ||
| 34.43x | 21.05x | 0.69x | 12.54x | 25.95x | 26.79x | 0.57% | 1,054B | ||
| 27.51x | 6.92x | -1.83x | 6.31x | 17.15x | 18.96x | 2.07% | 621B | ||
| 30.73x | 4502.54x | 0.13x | 7.36x | 15.07x | 15.56x | 2.77% | 438B | ||
| 17.67x | 6.54x | 1.06x | 4.38x | 10.82x | 12.16x | 3.03% | 325B | ||
| 21.42x | 6.39x | -29.73x | 5.5x | 13.31x | 14.55x | 2.87% | 281B | ||
| 21.07x | 4.94x | 0.94x | 4.44x | 12.4x | 13.27x | 1.98% | 262B | ||
| 14.26x | 6.28x | -11.48x | 5.33x | 10.96x | 12.83x | 3.5% | 219B | ||
| 23.64x | 18.19x | 3.31x | 6.27x | 11.07x | 14.34x | 2.8% | 195B | ||
| -47.34x | 8.29x | 0.34x | 5.67x | 31.3x | 62.45x | 2.47% | 163B | ||
| 12.43x | 1.59x | 0.28x | 3.06x | 7.74x | 8.73x | 7.05% | 140B | ||
| 27.4x | 5.5x | 1.9x | 8.28x | 18.68x | 19.53x | -.--% | 122B | ||
| 11.65x | 5.21x | 0.25x | 3.17x | 8.45x | 9.2x | 4.24% | 121B | ||
| 12.37x | 4.5x | 1.04x | 2.75x | 8.04x | 9.1x | 3.57% | 104B | ||
| 11.64x | 1.23x | 3.29x | 2.18x | 6.98x | 7.95x | 5.52% | 106B | ||
| 23.39x | 5.3x | 1.36x | 7.92x | 14.97x | 15.66x | 1.89% | 73.3B | ||
| 21.09x | 1.75x | -0.13x | 1.77x | 8.41x | 14.12x | 0.46% | 55.91B | ||
| 39.74x | 5.38x | 2.11x | 9x | 29.95x | 30.85x | 0.48% | 54.26B | ||
| 43.24x | 1.14x | 52.86x | 2.65x | 9.76x | 27.02x | 3.84% | 51.76B | ||
| 18.85x | 1.9x | 4.02x | 3.43x | 12.86x | 14.44x | 2.19% | 43.02B | ||
| Average | 18.87x | 242.87x | 1.52x | 5.37x | 14.42x | 18.29x | 2.7% | 221.34B | |
| Weighted average by Cap. | 22.86x | 454.93x | -1.37x | 7.13x | 16.93x | 19.48x | 2.27% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















